Article info

Download PDFPDF
T4 Cardiac fibroblast P38α map kinase is essential for cardiomyocyte hypertrophy and cardiac dysfunction following myocardial injury

Authors

  • SA Bageghni Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre (MCRC), School of Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • KE Hemmings Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre (MCRC), School of Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • KE Porter Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre (MCRC), School of Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • JFX Ainscough Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre (MCRC), School of Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • MJ Drinkhill Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre (MCRC), School of Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • NA Turner Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre (MCRC), School of Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles

Citation

Bageghni S, Hemmings K, Porter K, et al
T4 Cardiac fibroblast P38α map kinase is essential for cardiomyocyte hypertrophy and cardiac dysfunction following myocardial injury

Publication history

  • First published October 26, 2016.
Online issue publication 
October 26, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.